News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News Women Stand to Gain the Most From Standardized STEMI Protocols Michael O'Riordan September 30, 2021
News Features When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles Todd Neale September 28, 2021
News Daily News Score May Help Guide VITT Management After COVID-19 Vaccination Todd Neale September 23, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Largest Study of VITT After COVID-19 Vaccination Digs Into Lab, Clinical Features Todd Neale August 11, 2021
News Daily News Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t Shelley Wood August 04, 2021
News Conference News HRS 2021 STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation Todd Neale July 29, 2021
News Daily News Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b Shelley Wood June 22, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Daily News AHA/ASA Offers Advice on Rare Blood Clots Seen After Vaccines for COVID-19 Todd Neale April 30, 2021
News Conference News EHRA 2021 EHRA Updates Its Popular ‘Practical’ NOAC Guide Todd Neale April 29, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021